Correction to: Rare Adverse Events with Programmed Death-1 and Programmed Death-Ligand 1 Inhibitors: Justification and Rationale for a Systematic Review (Current Oncology Reports, (2021), 23, 8, (86), 10.1007/s11912-021-01089-9)

Caleb J. Smith, Yahya Almodallal, Aminah Jatoi

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Correction to: Rare Adverse Events with Programmed Death-1 and Programmed Death-Ligand 1 Inhibitors: Justification and Rationale for a Systematic Review (Current Oncology Reports, (2021), 23, 8, (86), 10.1007/s11912-021-01089-9)'. Together they form a unique fingerprint.

Medicine & Life Sciences